-
DiaSino celebrated its moving to new manufacturing center, R&D center and offices
2020-11-29
-
DiaSino has launched one-step method HE4 and CA125 ELISAs that can be used for monitoring and management of ovarian cancer
2020-08-24
-
DIASINO HAS LAUNCHED IL-6, PCT AND CRP FOR DIAGNOSIS OF SEPSIS
2020-06-29
-
DIASINO® LAUNCHES SPECIFIC SARS-COV-2 S1-RBD IGG ELISA AFTER TOTAL AB AND IGM ELISAS
2020-04-19
-
DIASINO®️ LAUNCHED SARS-COV-2 TOTAL ANTIBODY AND IGM ELISA FOR SCREENING OF CORONAVIRUS DISEASE
2020-04-01
-
DIASINO HAS LAUNCHED QUANTITATIVE H.PYLORI IGG ELISA
2020-02-29
-
DIASINO HAS ATTENDED MEDLAB MIDDLE EAST THAT WERE HELD IN DUBAI BETWEEN FEB 3-6, 2020
2020-02-08
-
DIASINO TO ATTEND MEDLAB MIDDLE EAST WHICH WILL BE HELD IN DUBAI BETWEEN FEB 3-6, 2020.
2020-01-06
-
DIASINO HAS LAUNCHED ONE-STEP SANDWICH INHIBIN B ELISA WITH ONLY 80 MINUTES INCUBATION TIME
2019-11-12
-
DIASINO®️ TO LAUNCH SMALL SIZE CLINICAL CHEMISTRY REAGENTS WHICH ARE USED FOR MANUAL TESTING
2019-10-30
-
DIASINO AMH ELISA REACHES 99% CORRELATION TO ROCHE ASSAY ON CLINICAL COMPARISON
2019-08-29
-
DIASINO ATTENDS AACC 2019 EXHIBITION WHICH WERE HELD IN ANAHEIM FROM AUGUST 6-8, 2019
2019-08-15
